[1]王高峰 管丽华 周达新.慢性血栓栓塞性肺动脉高压新治疗方法的进展[J].心血管病学进展,2022,(1):14-17.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.004]
　WANG Gaofeng,GUAN Lihua,ZHOU Daxin.Chronic Thromboembolic Pulmonary HypertensionEvolving Therapeutic Approaches[J].Advances in Cardiovascular Diseases,2022,(1):14-17.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.004]
点击复制

慢性血栓栓塞性肺动脉高压新治疗方法的进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年1期
页码:
14-17
栏目:
出版日期:
2022-01-25

文章信息/Info

Title:
Chronic Thromboembolic Pulmonary HypertensionEvolving Therapeutic Approaches
作者:
王高峰 管丽华 周达新
(复旦大学附属中山医院心血管内科,上海 200032)
Author(s):
WANG Gaofeng; GUAN Lihua; ZHOU Daxin
(Department of Cardiology,Zhongshan Hospital,Fudan University,Shanghai 200032,China)
关键词:
慢性血栓栓塞性肺动脉高压;  肺动脉内膜剥脱术;  球囊肺血管成形术; 靶向药物
Keywords:
Chronic thromboembolic pulmonary hypertension; Pulmonary endarterectomy; Balloon pulmonary angioplasty ; Targeted drugs
DOI:
10.16806/j.cnki.issn.1004-3934.2022.01.004
摘要:
慢性血栓栓塞性肺动脉高压是由于肺动脉血栓未完全溶解导致的一类毛细血管前性肺动脉高压。肺动脉内膜剥脱术是目前慢性血栓栓塞性肺动脉高压的首选治疗方案。但很多患者因远端血管病变或严重合并症而无法手术，或手术后有持续性肺动脉高压，球囊肺血管成形术和靶向药物的发展为这些患者的治疗带来了新的希望。现就慢性血栓栓塞性肺动脉高压新疗法的进展做一综述。
Abstract:
Chronic thromboembolic pulmonary hypertension is a type of precapillary pulmonary hypertension resulting from incomplete resolution of pulmonary embolism. At present,pulmonary endarterectomy is the preferred therapy. However,many patients are inoperable due to either distal pulmonary vascular obstruction or significant comorbidities,and some patients have persistent pulmonary hypertension after undergoing pulmonary endarterectomy. The development of balloon pulmonary angioplasty and targeted drugs have brought new hope to these patients. The paper reviews the evolving therapeutic approaches for chronic thromboembolic pulmonary hypertension.

参考文献/References:

[1] Wilkens H,Konstantinides S,Lang IM,et al. Chronic thromboembolic pulmonary hypertension(CTEPH):Updated Recommendations from the Cologne Consensus Conference 2018[J]. Int J Cardiol,2018,272Ｓ:69-78.

[2] Ende-Verhaar YM,Cannegieter SC,Vonk Noordegraaf A,et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism:a contemporary view of the published literature[J]. Eur Respir J,2017,49(2):1601792.

[3] Pepke-Zaba J,Delcroix M,Lang I,et al. Chronic thromboembolic pulmonary hypertension(CTEPH):results from an international prospective registry[J]. Circulation,2011,124(18):1973-1981.

[4] Simonneau G,Montani D,Celermajer DS,et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J,2019,53(1):1801913.

[5] Madani MM,Auger WR,Pretorius V,et al. Pulmonary endarterectomy:recent changes in a single institution’s experience of more than 2,700 patients[J]. Ann Ｔhoracic Ｓurg,2012,94(1):97-103.

[6] Vuylsteke A,Sharples L,Charman G,et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery(PEACOG):a randomised controlled trial[J]. Lancet,2011,378(9800):1379-1387.

[7] Kim NH,Delcroix M,Jenkins DP,et al. Chronic thromboembolic pulmonary hypertension[J]. J Am Coll Cardiol,2013,62(25 suppl):D92-D99.

[8] Galiè N,Humbert M,Vachiery JL,et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology(ESC) and the European Respiratory Society(ERS):Endorsed by:Association for European Paediatric and Congenital Cardiology(AEPC),International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J,2016,37(1):67-119.

[9] Thistlethwaite PA,Kemp A,Du L,et al. Outcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension[J]. J Thorac Cardiovasc Surg,2006,131(2):307-313.

[10] Mayer E,Jenkins D,Lindner J,et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension:results from an international prospective registry[J]. J Thorac Cardiovasc Surg,2011,141(3):702-710.

[11] Delcroix M,Lang I,Pepke-Zaba J,et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension:results from an international prospective registry[J]. Circulation,2016,133(9):859-871.

[12] Cannon JE,S u L,K iely DG,et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy:results from the United Kingdom National Cohort[J]. Circulation,2016,133(18):1761-1771.

[13] Korsholm K,Andersen A,Mellemkj?r S,et al. Results from more than 20 years of surgical pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension in Denmark[J]. Eur J Cardiothorac Surg,2017,52(4):704-709.

[14] 刘盛,朱家德,宋云虎. 阜外医院147例肺动脉内膜剥脱术单中心经验及远期结果[J]. 中国循环杂志,2017,32(z1):115-116.

[15] Kerr KM,Auger WR,Marsh JJ,et al. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy[J]. Chest,2012,141(1):27-35.

[16] Berman M,Tsui S,Vuylsteke A,et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy[J]. Ann Thorac Surg,2008,86(4):1261-1267.

[17] 钟冬祥,管丽华,周达新. 经皮肺动脉成形术在慢性血栓栓塞性肺动脉高压应用中的研究进展[J]. 心血管病学进展,2019,40(5):693-696.

[18] Voorburg JA,Cats VM,Buis B,et al. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism[J]. Chest,1988,94(6):1249-1253.

[19] Feinstein JA,G oldhaber SZ,L ock JE,et al. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension[J]. Circulation,2001,103(1):10-13.

[20] Mizoguchi H,Ogawa A,Munemasa M,et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension[J]. Circ Cardiovasc Interv,2012,5(6):748-755.

[21] Taniguchi Y,Miyagawa K,Nakayama K,et al. Balloon pulmonary angioplasty:an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension[J]. EuroIntervention,2014,10(4):518-525.

[22] Ogawa A,Satoh T,Fukuda T,et al. Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension:results of a multicenter registry[J]. Circ Cardiovasc Qual Outcomes,2017,10(11):e004029.

[23] Araszkiewicz A,Darocha S,Pietrasik A,et al. Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy[J]. Int J Cardiol,2019,278:232-237.

[24] Tsuji A,Ogo T,Demachi J,et al. Rescue balloon pulmonary angioplasty in a rapidly deteriorating chronic thromboembolic pulmonary hypertension patient with liver failure and refractory infection[J]. Pulm Circ,2014,4(1):142-147.

[25] Nakamura M,Sunagawa O,Tsuchiya H,et al. Rescue balloon pulmonary angioplasty under veno-arterial extracorporeal membrane oxygenation in a patient with acute exacerbation of chronic thromboembolic pulmonary hypertension[J]. Int Heart J,2015,56(1):116-120.

[26] Wiedenroth CB,Liebetrau C,Breithecker A,et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension[J]. J Heart Lung Transplant,2016,35(5):591-596.

[27] Inami T,Kataoka M,Shimura N,et al. Pulmonary edema predictive scoring index(PEPSI),a new index to predict risk of reperfusion pulmonary edema and improvement of hemodynamics in percutaneous transluminal pulmonary angioplasty[J]. JACC Cardiovasc Interv,2013,6(7):725-736.

[28] Inami T,Kataoka M,Shimura N,et al. Pressure-wire-guided percutaneous transluminal pulmonary angioplasty:a breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension[J]. JACC Cardiovasc Interv,2014,7(11):1297-1306.

[29] Hosokawa K,Abe K,Oi K,et al. Balloon pulmonary angioplasty-related complications and therapeutic strategy in patients with chronic thromboembolic pulmonary hypertension[J]. Int J Cardiol,2015,197:224-226.

[30] Ghofrani HA,D’Armini AM,Grimminger F,et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension[J]. N Engl J Med,2013,369(4):319-329.

[31] Ghofrani HA,Simonneau G,D’Armini AM,et al. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension(MERIT-1):results from the multicentre,phase 2,randomised,double-blind,placebo-controlled study[J]. Lancet Respir Med,2017,5(10):785-794.

[32] Ja?s X,D’Armini AM,Jansa P,et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension:BENEFiT(Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension),a randomized,placebo-controlled trial[J]. J Am Coll Cardiol,2008,52(25):2127-2134.

相似文献/References:

[1]郭晓曦,综述,张慧敏,等.慢性血栓栓塞性肺动脉高压[J].心血管病学进展,2016,(3):323.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.029]
　GUO Xiaoxi,ZHANG Huimin.Chronic Thromboembolic Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(1):323.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.029]
[2]钟冬祥 管丽华 周达新.经皮肺动脉成形术在慢性血栓栓塞性肺动脉高压应用中的研究进展[J].心血管病学进展,2019,(5):693.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.008]
　ZHONG Dongxiang,GUAN Lihua,ZHOU Daxin.Percutaneous Transluminal Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2019,(1):693.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.008]
[3]胡美曦 黄志华 柳志红 赵智慧 罗勤 赵青.慢性血栓栓塞性肺动脉高压：构建动物模型的研究进展[J].心血管病学进展,2022,(3):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
　HU Meixi,HUANG Zhihua,LIU Zhihong,et al.Chronic Thromboembolic Pulmonary Hypertension: Advances in Constructing Animal Models[J].Advances in Cardiovascular Diseases,2022,(1):236.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]

更新日期/Last Update: 2022-02-16